0001209191-21-014434.txt : 20210225
0001209191-21-014434.hdr.sgml : 20210225
20210225180920
ACCESSION NUMBER: 0001209191-21-014434
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210225
DATE AS OF CHANGE: 20210225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: aMoon 2 Fund Limited Partnership
CENTRAL INDEX KEY: 0001744099
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 21682359
BUSINESS ADDRESS:
STREET 1: 34 YERUSHALAYIM RD.
CITY: RAANANA
STATE: L3
ZIP: 4350110
BUSINESS PHONE: 972(73)3989560
MAIL ADDRESS:
STREET 1: 34 YERUSHALAYIM RD.
CITY: RAANANA
STATE: L3
ZIP: 4350110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schindel Yair Chaim
CENTRAL INDEX KEY: 0001823758
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 21682358
MAIL ADDRESS:
STREET 1: YERUSHALAYIM ROAD 34
STREET 2: BEIT GAMLA ENTRANCE B
CITY: RA'ANANA
STATE: L3
ZIP: 4350110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001061027
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943295878
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-3500
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980709
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-02-24
0
0001061027
SUNESIS PHARMACEUTICALS INC
VIRX
0001744099
aMoon 2 Fund Limited Partnership
34 YERUSHALAIM ROAD
BEIT GAMLA, 6TH FLOOR
RA-ANANA, 4350110
L3
ISRAEL
0
0
1
0
0001823758
Schindel Yair Chaim
34 YERUSHALAIM ROAD
BEIT GAMLA, 6TH FLOOR
RA-ANANA
L3
ISRAEL
0
0
1
0
Common Stock
5359372
D
Common Stock
2032865
I
See Footnote
The reported shares are held of record by aMoon 2 Fund, Limited Partnership ("aMoon 2 Fund"). aMoon 2 Fund G.P. Limited Partnership ("aMoon 2 Fund G.P.") is the sole General Partner of aMoon 2 Fund and aMoon General Partner Ltd. ("aMoon General Partner") is the sole General Partner of aMoon 2 Fund G.P. Dr. Yair Schindel is the sole shareholder of aMoon General Partner. By virtue of such relationships, aMoon 2 Fund G.P., aMoon General Partner and Dr. Schindel may be deemed to have shared voting and investment power with respect to the shares held of record by aMoon 2 Fund. Each of aMoon 2 Fund G.P., aMoon General Partner and Dr. Schindel disclaims beneficial ownership of the shares held by aMoon 2 Fund except to the extent of its or his pecuniary interest therein, if any.
The reported shares are held of record by aMoon - VRCT SPV Limited Partnership ("aMoon - VRCT"). aMoon 2 Fund G.P. is the sole General Partner of aMoon - VRCT and aMoon General Partner is the sole General Partner of aMoon 2 Fund G.P. Dr. Schindel is the sole shareholder of aMoon General Partner. By virtue of such relationships, aMoon 2 Fund G.P., aMoon General Partner and Dr. Schindel may be deemed to have shared voting and investment power with respect to the shares held of record by aMoon - VRCT. Each of aMoon 2 Fund G.P., aMoon General Partner and Dr. Schindel disclaims beneficial ownership of the shares held by aMoon - VRCT except to the extent of its or his pecuniary interest therein, if any.
/s/ Yair Schindel, the sole shareholder of aMoon General Partner Ltd., the sole General Partner of aMoon 2 Fund G.P. Limited Partnership, the sole General Partner of aMoon 2 Fund, Limited Partnership
2021-02-24
/s/ Yair Schindel
2021-02-24